ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Rutgers Coronavirus Saliva Test Receives FDA Approval americanpharmaceuticalreview
April 21, 2020The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavir
Pharma Sources Insight January 2025
